Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: restless arm syndrome; Huge area of redness around injection site with rash; Lump under the injection site and swelling; a huge area of redness around the injection site; Fever; muscle aches; ran the whole gamut of side effects; Huge area of redness around injection site with rash and intense heat; lump under the injection site; Injection may have been given too far to the side of the muscle; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection may have been given too far to the side of the muscle), VACCINATION COMPLICATION (ran the whole gamut of side effects), VACCINATION SITE WARMTH (Huge area of redness around injection site with rash and intense heat), VACCINATION SITE MASS (lump under the injection site) and RESTLESS ARM SYNDROME (restless arm syndrome) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Small fiber neuropathy.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Apr-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection may have been given too far to the side of the muscle). On 25-Apr-2021, the patient experienced VACCINATION COMPLICATION (ran the whole gamut of side effects), VACCINATION SITE WARMTH (Huge area of redness around injection site with rash and intense heat), VACCINATION SITE MASS (lump under the injection site), VACCINATION SITE RASH (Huge area of redness around injection site with rash), VACCINATION SITE SWELLING (Lump under the injection site and swelling), VACCINATION SITE ERYTHEMA (a huge area of redness around the injection site), PYREXIA (Fever) and MYALGIA (muscle aches). On 07-May-2021, the patient experienced RESTLESS ARM SYNDROME (restless arm syndrome). On 24-Apr-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Injection may have been given too far to the side of the muscle) had resolved. At the time of the report, VACCINATION COMPLICATION (ran the whole gamut of side effects), VACCINATION SITE WARMTH (Huge area of redness around injection site with rash and intense heat), RESTLESS ARM SYNDROME (restless arm syndrome), VACCINATION SITE RASH (Huge area of redness around injection site with rash), VACCINATION SITE SWELLING (Lump under the injection site and swelling), VACCINATION SITE ERYTHEMA (a huge area of redness around the injection site), PYREXIA (Fever) and MYALGIA (muscle aches) outcome was unknown and VACCINATION SITE MASS (lump under the injection site) had not resolved.            A female patient of unknown age received the second dose of the Moderna vaccine on 24-Apr-2021 in her right arm deltoid muscle and was concerned that it "may have been given too far to the side of the muscle". The day after her vaccine, she experienced muscle aches, fever and "ran the whole gamut of side effects". What most concerned her was the development of "Covid-arm", which she described as a huge area of redness around the injection site, with a rash and intense heat, and a lump under the injection site and swelling. Two weeks post-vaccination, she was still left with a "little lump", and feared it might be infected. Her physician was unable to see her until the following week. Patient had a history of small fiber neuropathy, and described the feeling in the vaccinated arm as a "restless arm syndrome", almost like restless leg syndrome, which comes and goes. She felt the neuropathy "most in the shot area" and it sometimes went throughout her arm. She planned to go to a local Urgent Care facility as she did not want to wait a week to see her physician.   Concomitant product use and treatment information was not provided.  The patient gave consent for Safety follow up.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.